Abstract
An implantable system for drug delivery provides a new strategy for drug therapy, and typically involves a microfluidic chip produced with micro or nano-technology. Implantable systems have the flexibility to conform various schemes of drug release, including zero order, pulsatile, and on demand dosing, as opposed to a standard sustained release profile. Such an implantable system is classified as allowing either controllable or uncontrollable drug release after implantation, so an active or passive delivery system respectively. The performance and related applications of these systems vary. The key points of each technology are highlighted such as performance, working principle, fabrication methods, and dimensional constrains. We here review the implantable drug-delivery system in current research with a focus on application and chip performance, and comparison for passive and active delivery system.
Keywords: Drug delivery, Implant, MEMS, Microfluidic.
Current Topics in Medicinal Chemistry
Title:An Implantable Drug-delivery System on a Chip
Volume: 15 Issue: 15
Author(s): Meng-Shiue Lee, Da-Jeng Yao and Wensyang Hsu
Affiliation:
Keywords: Drug delivery, Implant, MEMS, Microfluidic.
Abstract: An implantable system for drug delivery provides a new strategy for drug therapy, and typically involves a microfluidic chip produced with micro or nano-technology. Implantable systems have the flexibility to conform various schemes of drug release, including zero order, pulsatile, and on demand dosing, as opposed to a standard sustained release profile. Such an implantable system is classified as allowing either controllable or uncontrollable drug release after implantation, so an active or passive delivery system respectively. The performance and related applications of these systems vary. The key points of each technology are highlighted such as performance, working principle, fabrication methods, and dimensional constrains. We here review the implantable drug-delivery system in current research with a focus on application and chip performance, and comparison for passive and active delivery system.
Export Options
About this article
Cite this article as:
Lee Meng-Shiue, Yao Da-Jeng and Hsu Wensyang, An Implantable Drug-delivery System on a Chip, Current Topics in Medicinal Chemistry 2015; 15(15) . https://dx.doi.org/10.2174/1568026615666150414121427
DOI https://dx.doi.org/10.2174/1568026615666150414121427 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Coronin Family and Human Disease
Current Protein & Peptide Science Cytokine Therapy for Cancer
Current Pharmaceutical Design Potentials of Hydrogels in Cancer Therapy
Current Cancer Therapy Reviews Testicular Cell Junction: A Novel Target for Male Contraception
Current Medicinal Chemistry Testosterone as Potential Effective Therapy in Treatment of Obesity in Men with Testosterone Deficiency: A Review
Current Diabetes Reviews Treatment of Hereditary Angioedema: Current Perspectives
Recent Patents on Inflammation & Allergy Drug Discovery Antiandrogens in Prostate Cancer Endocrine Therapy
Current Cancer Drug Targets Alkaloid-Metal Based Anticancer Agents
Current Topics in Medicinal Chemistry Transforming Growth Factor Beta in Pancreatic Cancer
Current Pharmaceutical Biotechnology Cancer Stem Cells: How can we Target them?
Current Medicinal Chemistry New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets Patent Selections
Recent Patents on Biomarkers Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar?
Anti-Cancer Agents in Medicinal Chemistry Notch-Associated MicroRNAs in Cancer
Current Drug Targets Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier
Current Pharmaceutical Design Editorial [Hot Topic: Role of Renin-Angiotensin System (RAS) in Cancer (Guest Editor: Hiroji Uemura)]
Current Cancer Drug Targets Bladder Cancer Stem Cells
Current Stem Cell Research & Therapy Colostral Proline-Rich Polypeptides - Immunoregulatory Properties and Prospects of Therapeutic Use in Alzheimers Disease
Current Alzheimer Research Tissue Distribution of Glutamate Carboxypeptidase II (GCPII) with a Focus on the Central and Peripheral Nervous System
Current Medicinal Chemistry The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry